Kiniksa Pharmaceuticals International, plc SEC filings KNSA
Kiniksa Pharmaceuticals International, plc has 776 filings in SEC EDGAR's recent list, going back to Feb 27, 2018. Its latest annual report, Form ARS, was filed on Apr 16, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Oct 27, 2026, covering the quarter ended Sep 30, 2026. The most recent current report (Form 8-K) was filed on Oct 27, 2026 (results of operations). The company's fiscal year ends on December 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| 8-K |
Current report
Results of operations
|
Oct 27, 2026 | Oct 27, 2026 |
| 8-K |
Current report
Officer or director change
|
Oct 22, 2026 | Oct 17, 2026 |
| 8-K |
Current report
Results of operations
|
Jul 28, 2026 | Jul 28, 2026 |
| 8-K |
Current report
Shareholder vote results
|
May 29, 2026 | May 29, 2026 |
| 8-K |
Current report
Material agreement
|
May 26, 2026 | May 21, 2026 |
| 8-K |
Current report
Officer or director change
|
May 1, 2026 | Apr 30, 2026 |
| 8-K |
Current report
Results of operations
|
Apr 28, 2026 | Apr 28, 2026 |
| 8-K |
Current report
Results of operations
|
Feb 24, 2026 | Feb 24, 2026 |
| 8-K |
Current report
Officer or director change
|
Jan 14, 2026 | Jan 10, 2026 |
| 8-K |
Current report
Results of operations
|
Jan 12, 2026 | Jan 12, 2026 |
| 8-K |
Current report
Results of operations
|
Oct 28, 2025 | Oct 28, 2025 |
| 8-K |
Current report
Regulation FD disclosure
|
Sep 3, 2025 | Sep 3, 2025 |
| 8-K |
Current report
Results of operations
|
Jul 29, 2025 | Jul 29, 2025 |
| 8-K |
Current report
Regulation FD disclosure
|
Jun 5, 2025 | Jun 5, 2025 |
| 8-K |
Current report
Shareholder vote results
|
Jun 3, 2025 | Jun 3, 2025 |
| 8-K |
Current report
Results of operations
|
Apr 29, 2025 | Apr 29, 2025 |
| 8-K |
Current report
Officer or director change
|
Apr 23, 2025 | Apr 17, 2025 |
| 8-K |
Current report
Agreement ended, Results of operations, Exit or restructuring costs
|
Feb 25, 2025 | Feb 21, 2025 |
| 8-K |
Current report
Results of operations
|
Jan 13, 2025 | Jan 13, 2025 |
| 8-K |
Current report
Results of operations
|
Oct 29, 2024 | Oct 29, 2024 |
| 8-K |
Current report
Officer or director change
|
Oct 7, 2024 | Oct 4, 2024 |
| 8-K |
Current report
Results of operations
|
Jul 23, 2024 | Jul 23, 2024 |
| 8-K |
Current report
Material agreement
|
Jun 25, 2024 | Jun 25, 2024 |
| 8-K |
Current report
Other events
|
Jun 14, 2024 | Jun 14, 2024 |
| 8-K |
Current report
Shareholder vote results
|
Jun 5, 2024 | Jun 5, 2024 |
| 8-K |
Current report
Results of operations
|
Apr 23, 2024 | Apr 23, 2024 |
| 8-K |
Current report
Regulation FD disclosure
|
Apr 2, 2024 | Apr 2, 2024 |
| 8-K |
Current report
Other events
|
Mar 29, 2024 | Mar 29, 2024 |
| 8-K |
Current report
Results of operations
|
Feb 28, 2024 | Feb 28, 2024 |
| 8-K |
Current report
Results of operations, Regulation FD disclosure
|
Jan 4, 2024 | Jan 4, 2024 |
| 8-K |
Current report
Results of operations
|
Oct 31, 2023 | Oct 31, 2023 |
| 8-K |
Current report
Results of operations
|
Jul 25, 2023 | Jul 25, 2023 |
| 8-K |
Current report
Shareholder vote results
|
Jun 7, 2023 | Jun 6, 2023 |
| 8-K |
Current report
Results of operations
|
May 2, 2023 | May 2, 2023 |
| 8-K |
Current report
Regulation FD disclosure
|
Mar 13, 2023 | Mar 10, 2023 |
| 8-K |
Current report
Results of operations
|
Feb 28, 2023 | Feb 28, 2023 |
| 8-K |
Current report
Results of operations
|
Jan 9, 2023 | Jan 9, 2023 |
| 8-K |
Current report
Results of operations
|
Nov 1, 2022 | Nov 1, 2022 |
| 8-K |
Current report
Material agreement, Results of operations, Regulation FD disclosure
|
Aug 3, 2022 | Aug 2, 2022 |
| 8-K |
Current report
Shareholder vote results
|
Jun 30, 2022 | Jun 29, 2022 |
| 8-K |
Current report
Results of operations
|
May 3, 2022 | May 3, 2022 |
| 8-K |
Current report
Material agreement, Results of operations, Regulation FD disclosure
|
Feb 22, 2022 | Feb 22, 2022 |
| 8-K |
Current report
Results of operations
|
Jan 10, 2022 | Jan 10, 2022 |
| 8-K |
Current report
Officer or director change
|
Jan 3, 2022 | Jan 3, 2022 |
| 8-K |
Current report
Results of operations
|
Nov 1, 2021 | Nov 1, 2021 |
| 8-K |
Current report
Results of operations
|
Aug 3, 2021 | Aug 3, 2021 |
| 8-K |
Current report
Shareholder vote results
|
Jul 6, 2021 | Jun 29, 2021 |
| 8-K |
Current report
Officer or director change
|
May 12, 2021 | May 6, 2021 |
| 8-K |
Current report
Results of operations
|
May 4, 2021 | May 4, 2021 |
| 8-K |
Current report
Officer or director change
|
Apr 28, 2021 | Apr 26, 2021 |
| 8-K |
Current report
Material agreement
|
Mar 3, 2021 | Mar 1, 2021 |
| 8-K |
Current report
Results of operations
|
Feb 23, 2021 | Feb 23, 2021 |
| 8-K |
Current report
Results of operations
|
Jan 11, 2021 | Jan 11, 2021 |
| 8-K |
Current report
Officer or director change
|
Dec 22, 2020 | Dec 16, 2020 |
| 8-K |
Current report
Material agreement
|
Nov 10, 2020 | Nov 6, 2020 |
| 8-K |
Current report
Results of operations
|
Nov 5, 2020 | Nov 5, 2020 |
| 8-K |
Current report
Regulation FD disclosure
|
Oct 26, 2020 | Oct 23, 2020 |
| 8-K |
Current report
Results of operations
|
Jul 30, 2020 | Jul 30, 2020 |
| 8-K |
Current report
Officer or director change
|
Jul 28, 2020 | Jul 25, 2020 |
| 8-K |
Current report
Material agreement, Results of operations, Unregistered share sale
|
Jul 24, 2020 | Jul 20, 2020 |
| 8-K |
Current report
Material agreement
|
Jul 15, 2020 | Jul 9, 2020 |
| 8-K |
Current report
Shareholder vote results
|
Jul 7, 2020 | Jun 30, 2020 |
| 8-K |
Current report
Regulation FD disclosure
|
Jun 29, 2020 | Jun 29, 2020 |
| 8-K |
Current report
Material agreement, Unregistered share sale
|
May 18, 2020 | May 13, 2020 |
| 8-K |
Current report
Results of operations
|
Apr 28, 2020 | Apr 28, 2020 |
| 8-K |
Current report
Regulation FD disclosure
|
Apr 22, 2020 | Apr 22, 2020 |
| 8-K |
Current report
Results of operations
|
Feb 26, 2020 | Feb 26, 2020 |
| 8-K |
Current report
Officer or director change
|
Feb 5, 2020 | Feb 4, 2020 |
| 8-K |
Current report
Results of operations, Regulation FD disclosure
|
Jan 13, 2020 | Jan 13, 2020 |
| 8-K |
Current report
Officer or director change
|
Dec 16, 2019 | Dec 10, 2019 |
| 8-K |
Current report
Officer or director change
|
Nov 14, 2019 | Nov 12, 2019 |
| 8-K |
Current report
Results of operations
|
Oct 28, 2019 | Oct 28, 2019 |
| 8-K |
Current report
Results of operations, Regulation FD disclosure
|
Aug 12, 2019 | Aug 12, 2019 |
| 8-K |
Current report
Shareholder vote results
|
Jun 4, 2019 | May 29, 2019 |
| 8-K |
Current report
Results of operations
|
May 2, 2019 | May 2, 2019 |
| 8-K |
Current report
Results of operations, Officer or director change
|
Mar 7, 2019 | Mar 4, 2019 |
| 8-K |
Current report
Unregistered share sale
|
Feb 1, 2019 | Jan 28, 2019 |
| 8-K |
Current report
Regulation FD disclosure
|
Jan 28, 2019 | Jan 28, 2019 |
| 8-K |
Current report
Material agreement
|
Nov 13, 2018 | Nov 12, 2018 |
| 8-K |
Current report
Results of operations
|
Nov 1, 2018 | Nov 1, 2018 |
| 8-K |
Current report
Regulation FD disclosure
|
Sep 17, 2018 | Sep 17, 2018 |
| 8-K |
Current report
Regulation FD disclosure
|
Sep 13, 2018 | Sep 13, 2018 |
| 8-K |
Current report
Results of operations
|
Aug 6, 2018 | Aug 6, 2018 |
| 8-K |
Current report
Bylaw or fiscal year change
|
May 29, 2018 | May 29, 2018 |
Showing 84 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Pharmaceutical Preparations (SIC 2834)
- Listed as
- KNSA (Nasdaq)
- Fiscal year ends
- December 31
- Headquarters
- London
- SEC filer status
- Large accelerated filer
- SEC CIK
- 1730430
- Former names
- Kiniksa Pharmaceuticals, Ltd. (until Jun 28, 2024)
Other Pharmaceutical Preparations companies
- ELI LILLY & Co LLY
- Johnson & Johnson JNJ
- AbbVie Inc. ABBV
- Merck & Co., Inc. MRK
- Novartis AG NVS
- Astrazeneca PLC AZN
- Abbott Laboratories ABT
- Novo Nordisk A S NVO
Source: SEC EDGAR filings. This is company-reported data, not investment advice.